Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Cboe UK CHF

PolyPeptide Group AG (PPGNZ.XC)

Compare
22.90
0.00
(0.00%)
At close: February 21 at 4:10:05 PM GMT
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
320,372
320,372
280,978
282,126
223,033
Cost of Revenue
315,730
315,730
228,987
182,426
151,108
Gross Profit
4,642
4,642
51,991
99,700
71,925
Operating Expense
41,110
41,110
39,384
35,535
27,547
Operating Income
-36,468
-36,468
12,607
64,165
44,378
Net Non Operating Interest Income Expense
-7,280
-7,280
-3,413
-3,095
-3,209
Pretax Income
-58,243
-58,243
7,567
59,848
37,685
Tax Provision
-6,803
-6,803
-200
12,590
6,350
Net Income Common Stockholders
-51,440
-51,440
7,767
47,258
31,335
Diluted NI Available to Com Stockholders
-51,440
-51,440
7,767
47,258
31,335
Basic EPS
-1.56
-1.56
0.24
1.47
1.04
Diluted EPS
-1.56
-1.56
0.24
1.47
1.04
Basic Average Shares
32,941
32,941
32,986
32,097
30,000
Diluted Average Shares
32,968
32,968
33,004
32,124
30,000
Total Operating Income as Reported
-36,468
-36,468
12,607
64,165
44,378
Total Expenses
356,840
356,840
268,371
217,961
178,655
Net Income from Continuing & Discontinued Operation
-51,440
-51,440
7,767
47,258
31,335
Normalized Income
-51,440
-51,440
7,767
47,258
31,608.40
Interest Income
54
54
9
8
106
Interest Expense
5,623
5,623
2,091
2,823
3,315
Net Interest Income
-7,280
-7,280
-3,413
-3,095
-3,209
EBIT
-52,620
-52,620
9,658
62,671
41,000
EBITDA
-22,151
-22,151
35,721
83,354
58,545
Reconciled Cost of Revenue
315,730
315,730
228,987
182,426
151,108
Reconciled Depreciation
30,469
30,469
26,063
20,683
17,545
Net Income from Continuing Operation Net Minority Interest
-51,440
-51,440
7,767
47,258
31,335
Total Unusual Items Excluding Goodwill
--
--
--
--
-329
Total Unusual Items
--
--
--
--
-329
Normalized EBITDA
-22,151
-22,151
35,721
83,354
58,874
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
--
--
-55.60
12/31/2020 - 6/22/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade